Sue Binder, MD, is Senior Advisor for Public Health Practice; Amandine Zoonekyndt, MPH, is a Program Coordinator; Callie McLean is a Graduate Research Assistant; Katherine Seib, MSPH, is Director of Programs; and Ellen A. Spotts Whitney, MPH, is Director; all at the International Association of National Public Health Institutes, Global Health Institute, Emory University, Atlanta, GA. Callie McLean is also a Graduate Research Assistant, Rollins School of Public Health; Emory University; Atlanta, GA. Alex Riolexus Ario, MD, is Director, Uganda National Institute of Public Health, Kampala, Uganda. Hervé Hien, MD, PhD, MPH, is Director General, National Public Health Institute, Ouagadougou, Burkina Faso. Natalie Mayet, MD, MPhil, is Deputy Director, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. Ilesh V. Jani, MD, PhD, is Director General, Instituto Nacional de Saúde, Maputo, Mozambique. Chikwe Ihekweazu, FFPH, MPH, is Director General and Elsie Ilori, MSc, is Director, Surveillance and Epidemiology Department; both at the Nigeria Centre for Disease Control, Abuja, Nigeria. Ebba Abate, PhD, MSc, is Director General, Ethiopian Public Health Institute, Addis Ababa, Ethiopia. Sabin Nsanzimana, MD, PhD, MSc, is Director General, Rwanda Biomedical Centre, Kigali, Rwanda. William Yavo, PharmD, PhD, is Deputy Director, Training and Research, Institut National de Santé Publique, Abidjan, Côte d'Ivoire. Wemboo Afiwa Halatoko, MD, MPH, MSc, is Director, Institut National d'Hygiène, Lomé, Togo. Shiva Murugasampillay, MD, is Director, Global Public Health, Geneva, Switzerland. Claude Millogo, MD, is a Consultant, International Association of National Public Health Institutes, Global Health Institute, Emory University, Ouagadougou, Burkina Faso. Edris Nikjooy, MS, is a Project Manager and Anne-Catherine Viso, PhD, is Director, International Association of National Public Health Institutes; Edris Nikjooy is also a Project Manager and Anne-Catherine Viso is Deputy to the Secretary-General, Science and International Office, Santé publique France; all in Saint-Maurice, France.
Health Secur. 2021 Sep-Oct;19(5):498-507. doi: 10.1089/hs.2021.0094. Epub 2021 Sep 8.
National public health institutes (NPHIs)-science-based governmental agencies typically part of, or closely aligned with, ministries of health-have played a critical part in many countries' responses to the COVID-19 pandemic. Through listening sessions with NPHI leadership, we captured the experiences of NPHIs in Africa. Our research was further supplemented by a review of the literature. To address issues related to COVID-19, NPHIs in Africa developed a variety of innovative approaches, such as working with the private sector to procure and manage vital supplies and address key information needs. Creative uses of technology, including virtual training and messaging from drones, contributed to sharing information and battling misinformation. Positive impacts of the pandemic response include increased laboratory capacity in many countries, modernized surveillance systems, and strengthened public-private partnerships; much of this enhanced capacity is expected to persist beyond the pandemic. However, several challenges remain, including the lack of staff trained in areas like bioinformatics (essential for genomic analysis) and the need for sustained relationships and data sharing between NPHIs and agencies not traditionally considered public health (eg, those related to border crossings), as well as the impact of the pandemic on prevention and control of non-COVID-19 conditions-both infectious and noncommunicable. Participants in the listening sessions also highlighted concerns about inequities in access to, and quality of, the public health services and clinical care with resultant disproportionate impact of the pandemic on certain populations. COVID-19 responses and challenges highlight the need for continued investment to strengthen NPHIs and public health infrastructure to address longstanding deficiencies and ensure preparedness for the next public health crisis.
国家公共卫生机构(NPHIs)-作为政府机构,通常隶属于卫生部,或与其密切相关-在许多国家应对 COVID-19 大流行的过程中发挥了关键作用。通过与 NPHI 领导层的交流会议,我们了解了非洲 NPHI 的经验。我们的研究还通过对文献的回顾得到了补充。为了解决与 COVID-19 相关的问题,非洲的 NPHIs 开发了各种创新方法,例如与私营部门合作采购和管理重要物资以及解决关键信息需求。创造性地使用技术,包括来自无人机的虚拟培训和信息传递,有助于信息共享和打击错误信息。大流行应对措施的积极影响包括许多国家实验室能力的提高、现代化的监测系统以及加强公私伙伴关系;预计这种增强的能力在大流行结束后仍将持续存在。然而,仍存在一些挑战,包括缺乏在生物信息学等领域接受过培训的工作人员(基因组分析必不可少),以及需要 NPHI 与传统上不被视为公共卫生机构(例如与过境点相关的机构)之间建立持续的关系和数据共享,以及大流行对预防和控制非 COVID-19 疾病(包括传染病和非传染性疾病)的影响。交流会议的参与者还强调了对公共卫生服务和临床护理获取机会和质量的不平等的担忧,这导致大流行对某些人群产生了不成比例的影响。COVID-19 的应对措施和挑战凸显了需要继续投资以加强 NPHI 和公共卫生基础设施,以解决长期存在的缺陷,并为下一次公共卫生危机做好准备。